Candel Therapeutics, Inc. (CADL) - Quarterly Balance Statement

Home
CADL
Financials

7.68 (USD) • At close September 19, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q1
Assets:
Current Assets:
Cash & Cash Equivalents Numbers are in millions	21.454	25.713	35.413	42.983	51.894	59.258	70.058	77.183	86.782	94.321	82.642	88.385	24.316	29.152	35.053	-45.057
Short Term Investments Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	90.114
Cash and Short Term Investments Numbers are in millions	21.454	25.713	35.413	42.983	51.894	59.258	70.058	77.183	86.782	94.321	82.642	88.385	24.316	29.152	35.053	45.057
Net Receivables Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Inventory Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Current Assets Numbers are in millions	1.281	1.423	1.384	2.118	1.468	2.617	1.887	1.887	0.544	1.325	2.303	2.565	0.11	0.319	0.093	0
Total Current Assets Numbers are in millions	22.735	27.136	36.797	45.101	53.362	61.875	71.945	79.07	87.326	95.646	84.945	90.95	24.426	29.471	35.146	45.057
Non-Current Assets:
Property, Plant & Equipment, Net Numbers are in millions	3.403	3.713	4.022	4.555	4.921	5.097	5.48	5.671	5.709	5.479	3.836	4.587	4.606	4.263	2.787	0
Goodwill Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Intangible Assets Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Goodwill and Intangible Assets Numbers are in millions	0	0	0	0	0	0	-1.094	0	0	0	0	0	0	0	0	0
Long Term Investments Numbers are in millions	0.266	0.266	0.266	0.266	0.266	0.266	0.266	0.266	0.266	0.437	0.424	0.423	0	0.423	0	0
Tax Assets Numbers are in millions	0	0	0.501	0	0	0	0.828	0	0	0	0	0	0	0	0	0
Other Non-Current Assets Numbers are in millions	0.081	0.102	0.116	0.139	0.159	0	0.266	0	0	0	0	0	1.712	0.937	0.349	-45.057
Total Non-Current Assets Numbers are in millions	3.75	4.081	4.905	4.96	5.346	5.363	5.746	5.937	5.975	5.916	4.26	5.01	6.318	5.623	3.136	-45.057
Total Assets Numbers are in millions	26.485	31.217	41.702	50.061	58.708	67.238	77.691	85.007	93.301	101.562	89.205	95.96	30.744	35.094	38.282	0
Liabilities & Equity:
Current Liabilities:
Account Payables Numbers are in millions	0.433	0.472	0.422	0.25	0.48	0.592	0.38	0.97	1.584	1.386	1.59	0.925	0.759	1.513	0.921	0
Short Term Debt Numbers are in millions	10.348	10.293	9.406	6.6	4.14	1.729	0.464	0.452	0.44	0.429	0	3.212	3.448	0.464	0.463	0
Tax Payables Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Deferred Revenue Numbers are in millions	0	0	0	0.108	0.12	0.132	0.144	0	0	0	0	0.031	0.063	3.298	3.142	0
Other Current Liabilities Numbers are in millions	3.215	2.772	4.356	3.369	3.423	2.783	4.627	4.476	3.854	3.657	3.772	0.229	0.224	0.223	0.187	0
Total Current Liabilities Numbers are in millions	13.996	13.537	14.184	10.327	8.163	5.236	5.615	5.898	5.878	5.472	5.362	4.397	4.494	5.498	4.713	0
Non-Current Liabilities:
Long Term Debt Numbers are in millions	7.515	9.955	12.383	16.171	18.64	21.06	22.336	22.356	22.355	22.363	0.56	0.541	0.521	0.502	0.483	0
Deferred Revenue Non-Current Numbers are in millions	0	0	0.973	0.108	0.12	0.132	0.144	0	0	0	0	0.031	0.063	0.094	0.125	0
Deferred Tax Liabilities Non-Current Numbers are in millions	0	0	0.501	-14.447	-16.823	0	0.828	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities Numbers are in millions	14.946	1.746	0.916	14.88	17.837	1.158	1.054	4.626	4.996	9.965	19.146	28.004	68.841	56.497	56.523	0
Total Non-Current Liabilities Numbers are in millions	22.461	11.701	14.773	16.712	19.774	22.35	24.362	26.982	27.351	32.328	19.706	28.576	69.425	57.093	57.131	0
Total Liabilities Numbers are in millions	36.457	25.238	28.957	27.039	27.937	27.586	29.977	32.88	33.229	37.8	25.068	32.973	73.919	62.591	61.844	0
Equity:
Preferred Stock Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	95.96	26.56	49.06	49.06	49.06
Common Stock Numbers are in millions	0.303	0.292	0.29	0.29	0.29	0.29	0.29	0.29	0.29	0.287	0.286	0.286	0.117	0.117	0.116	0
Retained Earnings Numbers are in millions	-167.486	-145.249	-137.028	-125.933	-117.498	-107.884	-99.089	-94.006	-85.318	-81.169	-80.295	-81.891	-65.729	-48.649	-44.171	0
Accumulated Other Comprehensive Income/Loss Numbers are in millions	0	0	-0	0	0	0	-0	0	0	-0	0	-95.96	-26.56	-0.16	-49.06	-8.038
Other Total Stockholders Equity Numbers are in millions	157.211	150.936	149.483	148.665	147.979	147.246	-0.29	145.843	145.1	144.644	144.146	144.592	22.437	-27.865	20.493	0
Total Shareholders Equity Numbers are in millions	-9.972	5.979	12.745	23.022	30.771	39.652	-99.089	52.127	60.072	63.762	64.137	62.987	-43.175	-27.497	-23.562	41.022
Total Equity Numbers are in millions	-9.972	5.979	12.745	23.022	30.771	39.652	-99.089	52.127	60.072	63.762	64.137	62.987	-43.175	-27.497	-23.562	41.022
Total Liabilities & Shareholders Equity Numbers are in millions	26.485	31.217	41.702	50.061	58.708	67.238	-69.112	85.007	93.301	101.562	89.205	95.96	30.744	35.094	38.282	41.022

Candel Therapeutics, Inc.

NASDAQ:CADL Add to watchlist

NASDAQ:CADL